When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XLRN - Acceleron Reignites Pipeline After Latest Trial Success With PAH Drug
Acceleron Pharma Inc.
Acceleron Pharma (XLRN) announced that it had achieved the primary endpoint in the phase 2 PULSAR study, treating patients with pulmonary arterial hypertension ((PAH)). This positive data is only the beginning for this program, because there is another phase 2 study known as SPECTRA, which has the potential to build upon the recent successful study. In addition, the biotech can now move on to initiate discussions with regulators, so that it can advance the drug sotatercept in a phase 3 study. If it can get the drug approved, it is likely to end